Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARACA: Prophylactic Amiodarone After Out-of-Hospital Cardiac Arrest
2023-510099-30-00Phase 3Authorised
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of amiodarone in cardiac arrest (SCA) (2 arms), sponsored by Centre Hospitalier de Versailles. Primary endpoint: Primary composite endpoint. Planned start Sep 2025; status: authorised.
02
Drugs
amiodarone
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2023-510099-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510099-30-00.